Saturna Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Saturna Capital’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,781	Closed	-$40K	–	186
2023 Q3	$40K	Hold	27,781	–	–	﹤0.01%	174
2023 Q2	$72.2K	Buy	27,781 +2,500	+10%	+$7.48K	﹤0.01%	166
2023 Q1	$93K	Buy	+25,281	New	+$106K	﹤0.01%	160
2022 Q2	–	Sell	-14,300	Closed	-$210K	–	173
2022 Q1	$210K	Hold	14,300	–	–	﹤0.01%	162
2021 Q4	$226K	Buy	14,300 +200	+1%	+$4.8K	﹤0.01%	162
2021 Q3	$453K	Buy	14,100 +150	+1%	+$5.27K	0.01%	136
2021 Q2	$580K	Buy	13,950 +9,100	+188%	+$374K	0.01%	127
2021 Q1	$246K	Buy	+4,850	New	+$254K	0.01%	155

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Saturna Capital's DMTK Position: Q4 2023 in Review

Saturna Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 27,781 shares — an estimated $40K sold.

Saturna Capital first reported a position in DMTK in Q1 2021 and held it in 8 quarters. The position peaked at $580K in Q2 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

Saturna Capital reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Saturna Capital sold 27,781 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $40K.
Saturna Capital first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Saturna Capital's DermTech, Inc. Common Stock position peaked at $580K in Q2 2021.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Saturna Capital's 13F filing for Q4 2023, filed 6 Feb 2024.